(19)
(11) EP 1 368 055 A2

(12)

(88) Date of publication A3:
09.01.2003

(43) Date of publication:
10.12.2003 Bulletin 2003/50

(21) Application number: 02702232.6

(22) Date of filing: 07.03.2002
(51) International Patent Classification (IPC)7A61K 38/26
(86) International application number:
PCT/DK0200/142
(87) International publication number:
WO 0206/9994 (12.09.2002 Gazette 2002/37)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.03.2001 US 800541
08.03.2001 WO PCT/DK01/00150
21.05.2001 DK 200100812
07.09.2001 US 949344
07.09.2001 DK 200101322
11.09.2001 DK 200101322
13.09.2001 US 951300

(71) Applicant: NOVO NORDISK A/S
2880 Bagsvaerd (DK)

(72) Inventors:
  • KNUDSEN, Liselotte, Bjerre
    DK-2500 Valby (DK)
  • WASSERMANN, Karsten
    DK-2820 Gentofte (DK)
  • STURIS, Jeppe
    DK-3500 Vaerloese (DK)
  • BRAND, Christian, Lehn
    DK-3450 Alleroed (DK)
  • GODTFREDSEN, Carsten, Foged
    DK-2730 Herlev (DK)

(74) Representative: Stahr, Pia et al
Novo Nordisk A/S,Corporate Patents,Novo Allé
2880 Bagsvaerd
2880 Bagsvaerd (DK)

   


(54) COMBINED USE OF DERIVATIVES OF GLP-1 ANALOGS AND PPAR LIGANDS